These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34412566)
1. 3D printing and enteric coating of a hollow capsular device with controlled drug release characteristics prepared using extruded Eudragit® filaments. Choudhury D; Murty US; Banerjee S Pharm Dev Technol; 2021 Nov; 26(9):1010-1020. PubMed ID: 34412566 [TBL] [Abstract][Full Text] [Related]
2. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
4. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171 [TBL] [Abstract][Full Text] [Related]
5. Feasibility study into the potential use of fused-deposition modeling to manufacture 3D-printed enteric capsules in compounding pharmacies. Nober C; Manini G; Carlier E; Raquez JM; Benali S; Dubois P; Amighi K; Goole J Int J Pharm; 2019 Oct; 569():118581. PubMed ID: 31369828 [TBL] [Abstract][Full Text] [Related]
6. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers. Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663 [TBL] [Abstract][Full Text] [Related]
8. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
9. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535 [TBL] [Abstract][Full Text] [Related]
10. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
11. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD). Leopold CS; Eikeler D J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233 [TBL] [Abstract][Full Text] [Related]
12. The manufacture and characterisation of hot-melt extruded enteric tablets. Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604 [TBL] [Abstract][Full Text] [Related]
13. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898 [TBL] [Abstract][Full Text] [Related]
14. 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion. Jamróz W; Kurek M; Czech A; Szafraniec J; Gawlak K; Jachowicz R Eur J Pharm Biopharm; 2018 Oct; 131():44-47. PubMed ID: 30048746 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468 [TBL] [Abstract][Full Text] [Related]
16. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
17. 3D printed capsules for quantitative regional absorption studies in the GI tract. Smith D; Kapoor Y; Hermans A; Nofsinger R; Kesisoglou F; Gustafson TP; Procopio A Int J Pharm; 2018 Oct; 550(1-2):418-428. PubMed ID: 30172750 [TBL] [Abstract][Full Text] [Related]
18. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014 [TBL] [Abstract][Full Text] [Related]
19. Development of enteric-coated timed-release matrix tablets for colon targeting. Alvarez-Fuentes J; Fernández-Arévalo M; González-Rodríguez ML; Cirri M; Mura P J Drug Target; 2004; 12(9-10):607-12. PubMed ID: 15621686 [TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole. Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]